Nicotine induced seizures blocked by mecamylamine and its stereoisomers

Life Sciences

Volumn 69, Issue 22, 2001, Pages 2583-2591

  Newman, Mary B ^a   Manresa, John J ^a   Sanberg, Paul R ^a   Shytle, R Douglas ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Convulsions; Isomers; Mecamylamine; Nicotine; Rat; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; MECAMYLAMINE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DESIGN; DRUG EFFECT; ISOMER; LATENT PERIOD; LOCOMOTION; MALE; NONHUMAN; RACEMIC MIXTURE; RAT; SEIZURE; STEREOISOMERISM;

EID: 0035914214     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01338-8     Document Type: Article

References (30)

1. Tolerance to the convulsions induced by daily nicotine treatment in rats
2. Effects of acute administration of nicotine on convulsive movements and blood levels of corticosterone in old rats
3. Pharmacological characterization of nicotine-induced seizures in mice
4. Nicotine-induced convulsions in cats and central nicotinic receptors
5. Chronic nicotine pretreatment protects the blood-brain barrier against nicotine-induced seizures in the rat
6. Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors
7. Properties underlying the influence of nicotinic receptors on neuronal excitability and epilepsy
8. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epileps
9. Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: An association study
10. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy
11. The nicotinic receptor beta2 subunit is mutant in nocturnal frontal lobe epilepsy
12. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices
13. Effects of cholinergic drugs on genetic absence seizures in rats
14. Mecamylamine blockade of nicotine responses: Evidence for two brain nicotinic receptors
15. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes
16. Chemistry and structure-activity relationships of mecamylamine and derivatives
17. Synthesis of 2-exo- and 2-endo-mecamyl-amine analogues. Structure- activity relationships for nicotinic antagonism in the central nervous system
18. Preparation of optically active secondary amines by thermal decomposition of (methylbenzyl) urea analogs: Absolute configuration of (+)- and (-)-mecamylamine
19. Automated measurement of multivariate locomotor behavior in rodents
20. Developmental changes in seizure susceptibility during ethanol withdrawal
21. 3H-(1-[1-(2-Thienyl)cyclohexyl]-Piperidine) binding in rat hippocampus
22. [3H]MK801 binding to the N-methyl-D-aspartate receptor reveals drug interactions with the zinc and magnesium binding sites
23. Both nicotine and mecamylamine block dizocilpine-induced explosive jumping behavior in mice: Psychiatric implications
24. A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs
25. Multi-center double blind placebo controlled study of mecamylamine monotherapy for tourette's disorder
26. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment
27. Up-regulation of cell-surface alpha4beta2 neuronal nicotinic receptors by lower temperature and expression of chimeric subunits
28. Genetic basis of the human epilepsies
29. Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine
30. Nicotine-sensitive paresis